ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The T-cell-specific cell-surface receptors CD28 and CTLA-4 are important regulators of the immune system. CD28 potently enhances those T-cell functions that are essential for an effective antigen-specific immune response, and the homologous CTLA-4 counterbalances the CD28-mediated signals and thus prevents an otherwise fatal overstimulation of the lymphoid system. Here we report the identification of a third member of this family of molecules, inducible co-stimulator (ICOS), which is a homodimeric protein of relative molecular mass 55,000-60,000 (M(r) 55K-60K). Matching CD28 in potency, ICOS enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, upregulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B cells. Unlike the constitutively expressed CD28, ICOS has to be de novo induced on the T-cell surface, does not upregulate the production of interleukin-2, but superinduces the synthesis of interleukin-10, a B-cell-differentiation factor. In vivo, ICOS is highly expressed on tonsillar T cells, which are closely associated with B cells in the apical light zone of germinal centres, the site of terminal B-cell maturation. Our results indicate that ICOS is another major regulator of the adaptive immune system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune co-stimulator (ICOS) is a co-stimulatory molecule expressed on T cells, which enhances function and expansion of CD8+ T cells and Tregs (Fu et al., 2011; Hutloff et al., 1999; Liakou et al., 2008).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Hutloff et al., 1999
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
The Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.381 · Cited by 2,254
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
MacLennan, I. C. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.117 · Cited by 1,729
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239 · cited 1×
“Protein material from five gels was pooled, in situ -digested with trypsi”
Method
Cited by
Items 601–700 of 1,001
Transplantation tolerance: The concept and its applicability
Dong, V. M., Womer, K. L., & Sayegh, M. H. (1999) · Pediatric Transplantation · doi:10.1034/j.1399-3046.1999.00042.x · Cited by 52
Tezuka, K., Tsuji, T., Hirano, D., Tamatani, T., Sakamaki, K., Kobayashi, Y., & Kamada, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3466 · Cited by 42
Immune checkpoint inhibitors in infectious disease
King, H. A. D., & Lewin, S. R. (2024) · Immunological Reviews · doi:10.1111/imr.13388 · Cited by 43
Transcriptomic Signature of the CD
Bigot, J., Pilon, C., Matignon, M., Grondin, C., Leibler, C., Aissat, A., Pirenne, F., Cohen, J. L., & Grimbert, P. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13904 · Cited by 41
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo
Gigliotti, C. L., Boggio, E. M., Clemente, N., Shivakumar, Y., Toth, E., Sblattero, D., D’Amelio, P., Isaia, G. C., Dianzani, C., Yagi, J., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600424 · Cited by 42
A Pilot Trial Targeting the ICOS–ICOS-L Pathway in Nonhuman Primate Kidney Transplantation
Lo, D. J., Anderson, D. J., Song, M., Leopardi, F., Farris, A. B., Strobert, E. A., Chapin, S. J., Devens, B. H., Karrer, E. E., & Kirk, A. D. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13100 · Cited by 41
Immune Regulation by Novel Costimulatory Molecules
Dong, C., Nurieva, R., & Prasad, D. V. R. (2003) · Immunologic Research · doi:10.1385/ir:28:1:39 · Cited by 41
Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells
Janke, M., Witsch, E., Mages, H. W., Hutloff, A., & Kroczek, R. A. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02379.x · Cited by 41
Self-citationBeyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity
Nirmala, S. S., Kayani, K., Gliwiński, M., Hu, Y., Iwaszkiewicz‐Grześ, D., Piotrowska, M., Sakowska, J., Tomaszewicz, M., Morales, J. M. M., Lakshmi, K., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1321228 · Cited by 45
Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
Prevel, N., Allenbach, Y., Klatzmann, D., Salomon, B. L., & Benvéniste, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074450 · Cited by 42
“La molécule ICOS (pour « Inducible CO-Stimulator ») est elle aussi issue de la famille CD28 (Hutloff et al., 1999).”
BackgroundClemente, N., Boggio, E. M., Gigliotti, C. L., Raineri, D., Ferrara, B., Miglio, G., Argenziano, M., Chiocchetti, A., Cappellano, G., Trotta, F., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.030 · Cited by 40
Immune modulation in corneal transplantation
Fu, H., Larkin, F., & George, A. J. T. (2008) · Transplantation Reviews · doi:10.1016/j.trre.2007.12.005 · Cited by 42
“Despite this, it has been demonstrated that signaling through ICOS is important in T-cell activation and proliferation [71].”
BackgroundMaeda, S., Fujimoto, M., Matsushita, T., Hamaguchi, Y., Takehara, K., & Hasegawa, M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.048 · Cited by 44
Wilson, E. H., Zaph, C., Mohrs, M., Welcher, A., Siu, J., Artis, D., & Hunter, C. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2365 · Cited by 45
Tsai, H.-F., Lai, J., Chou, A., Wang, T., Wu, C., & Hsu, P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20038 · Cited by 42
Hanson, A., Elpek, K., Duong, E., Shallberg, L., Fan, M., Johnson, C., Wallace, M., Mabry, G. R., Sazinsky, S., Pepper, L., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239595 · Cited by 39
“initial T cell priming by antigen [4].”
Littwitz-Salomon, E., Malyshkina, A., Schimmer, S., & Dittmer, U. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01947 · Cited by 42
“Furthermore, we analyzed the activation of Tregs by the early activation marker CD69, the inducible costimulator ICOS (CD278) and the Programmed cell death ligand 1 (PD-L1, CD274) that are upregulated on activated T cells (32, 33).”
Methodde Vos, L., Grünwald, I., Bawden, E., Dietrich, J., Scheckenbach, K., Wiek, C., Zarbl, R., Bootz, F., Landsberg, J., & Dietrich, D. (2020) · Epigenetics · doi:10.1080/15592294.2020.1754675 · Cited by 42
Nayar, S., Pontarini, E., Campos, J., Berardicurti, O., Smith, C. G., Asam, S., Gardner, D. H., Colafrancesco, S., Lucchesi, D., Coleby, R., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03344-6 · Cited by 43
The signaling tool box for tyrosine-based costimulation of lymphocytes
Engels, N., & Wienands, J. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.01.005 · Cited by 44
Kurosawa, S., Myers, A. C., Chen, L., Wang, S., Ni, J., Plitt, J. R., Heller, N. M., Bochner, B. S., & Schleimer, R. P. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0199oc · Cited by 39
ICOS-Induced B7h Shedding on B Cells Is Inhibited by TLR7/8 and TLR9
Logue, E. C., Bakkour, S., Murphy, M. M., Nolla, H. A., & Sha, W. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2356 · Cited by 45
Vieira, P. L., Wassink, L., Taylor-Smith, L. M., Nam, S., Kingsbury, G. A., Gutierrez-Ramos, J.-C., Coyle, A. J., Kapsenberg, M. L., & Wierenga, E. A. (2004) · European Journal of Immunology · doi:10.1002/eji.200324417 · Cited by 39
ICOS is essential for the development of experimental autoimmune myasthenia gravis
Scott, B. G., Yang, H., Tüzün, E., Dong, C., Flavell, R. A., & Christadoss, P. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.04.019 · Cited by 39
Follicular CD8+ T Cells: Origin, Function and Importance during HIV Infection
Perdomo-Celis, F., Taborda, N. A., & Rugeles, M. T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01241 · Cited by 41
Cai, G., Sun, K., Xia, S., Feng, Z., Zou, H., Gu, J., Yuan, Y., Zhu, J., Liu, Z., & Bian, J. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126999 · Cited by 38
Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas
dos Santos, L. V., Abrahão, C. M., & William, W. N. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.596290 · Cited by 43
Triggering of B7h by the ICOS Modulates Maturation and Migration of Monocyte-Derived Dendritic Cells
Occhipinti, S., Dianzani, C., Chiocchetti, A., Boggio, E. M., Clemente, N., Gigliotti, C. L., Soluri, M. F., Minelli, R., Fantozzi, R., Yagi, J., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201816 · Cited by 38
Predominantly Antibody Deficiencies
Aghamohammadi, A., Lougaris, V., Plebani, A., Miyawaki, T., Durandy, A., & Hammarström, L. L. G. (2008) · Springer eBooks · doi:10.1007/978-3-540-78936-9_3 · Cited by 39
Wu, J., Tang, J., Wu, S., Lio, H., & Yang, Y. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.03.037 · Cited by 38
Mechanisms of H4/ICOS costimulation: effects on proximal TCR signals and MAP kinase pathways
Rojo, J. M., Vaschetto, R., Criado, G., Sánchez, A., Chiocchetti, A., Jiménez‐Periáñez, A., Dianzani, U., Portolés, P., & Rojo, J. M. (2002) · European Journal of Immunology · doi:10.1002/immu.200390023 · Cited by 38
Rutitzky, L. I., Özkaynak, E., Rottman, J. B., & Stadecker, M. J. (2003) · Infection and Immunity · doi:10.1128/iai.71.7.4040-4044.2003 · Cited by 38
Targeting of the immune system in systemic lupus erythematosus
Ramanujam, M., & Davidson, A. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000562 · Cited by 40
Chevalier, M. F., Didier, C., Petitjean, G., Karmochkine, M., Girard, P., Barré‐Sinoussi, F., Scott‐Algara, D., & Weiss, L. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu549 · Cited by 41
Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy
Amon, L., Hatscher, L., Heger, L., Dudziak, D., & Lehmann, C. H. K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070663 · Cited by 41
Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer
Song, J., & Wu, L. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00148 · Cited by 43
Reverse signaling using an inducible costimulator to enhance immunogenic function of dendritic cells
Tang, G., Qin, Q., Zhang, P., Wang, G., Liu, M., Ding, Q., Qin, Y., & Shen, Q. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0090-7 · Cited by 40
Garapati, P. V., & Lefranc, M. (2007) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2007.01.008 · Cited by 37
Foy, S. P., Mandl, S. J., Cruz, T. D., Cote, J. J., Gordon, E. J., Trent, E., Delcayre, A. X., Breitmeyer, J. B., Franzusoff, A., & Rountree, R. B. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1816-7 · Cited by 41
Zhang, G. ‐., Zhou, H., Chen, Y. ‐., Ge, Y., Xie, F., Shi, Q., Ma, H., Fei, M., & Zhang, X. (2005) · Tissue Antigens · doi:10.1111/j.1399-0039.2005.00449.x · Cited by 37
Duperrier, K., Velten, F., Bohlender, J., Demory, A., Metharom, P., & Goerdt, S. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.01.006 · Cited by 37
Vaschetto, R., Grinstein, J., Sorbo, L. D., Khine, A. A., Voglis, S., Tullis, E. D., Slutsky, A. S., & Zhang, H. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0706435 · Cited by 37
“In addition, the CD28 family includes CTLA-4 or CD152, which binds to B7-1 (CD80) on APC [17].”
BackgroundInfluentialExpanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS Deficiency
Abolhassani, H., El-Sherbiny, Y. M., Arumugakani, G., Carter, C. R. D., Richards, S. J., Lawless, D., Wood, P. M. D., Buckland, M. S., Arani, M. H., Aghamohammadi, A., et al. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00735-z · Cited by 36
Qian, X., Agematsu, K., Freeman, G. J., Tagawa, Y., Sugane, K., & Hayashi, T. (2006) · European Journal of Immunology · doi:10.1002/eji.200535253 · Cited by 41
Co‐Stimulatory Blockade in the Treatment of Murine Systemic Lupus Erythematosus (SLE)
Davidson, A., Wang, X., Mihara, M., Ramanujam, M., Huang, W., Schiffer, L. E., & Sinha, J. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06048.x · Cited by 36
Yagi, J., Arimura, Y., Dianzani, U., Uede, T., Okamoto, T., & Uchiyama, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.783 · Cited by 37
Human B cell defects in perspective
Cunningham‐Rundles, C. (2012) · Immunologic Research · doi:10.1007/s12026-012-8318-2 · Cited by 39
Immune checkpoint-based therapy in myeloid malignancies: a promise yet to be fulfilled
Bewersdorf, J. P., Stahl, M. F., & Zeidan, A. M. (2019) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1589374 · Cited by 36
“as a predictive response biomarker [13,16,52].”
Distinct roles of ICOS and CD40L in human T-B cell adhesion and antibody production
Liu, Z., Liu, S., Zhang, Y., Zeng, W., Wang, S., Ji, P., Pan, M., Zhu, C., & Wang, Y. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104420 · Cited by 35
Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia
Hanna, G. J., Villa, A., Mistry, N., Jia, Y., Quinn, C. T., Turner, M. M., Felt, K. D., Pfaff, K. L., Haddad, R. I., Uppaluri, R., et al. (2021) · Cancer Research Communications · doi:10.1158/2767-9764.crc-21-0060 · Cited by 35
The application of immune checkpoint blockade in breast cancer and the emerging role of nanoparticle
Masoumi, E., Tahaghoghi-Hajghorbani, S., Jafarzadeh, L., Sanaei, M., Pourbagheri‐Sigaroodi, A., & Bashash, D. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.10.018 · Cited by 35
Abdeladhim, M., Karnell, J. L., & Rieder, S. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1033705 · Cited by 40
“First identified in humans two decades ago, ICOS is the third member of the CD28 co-stimulatory family that is expressed on different populations of activated T cells comprising CD8+ cytotoxic T lymphocytes (CTL), CD4+ (Th1, Frontiers in Immunology 05 Th2, Th17 and Tfh) and CD4+Foxp3+ Tregs (56).”
BackgroundInfluentialCha, Z., Qian, G., Zang, Y., Gu, H., Huang, Y., Zhu, L., Li, J., Liu, Y., Tu, X., Song, H., et al. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.017 · Cited by 38
Activation and inhibition of lymphocytes by costimulation
Frauwirth, K. A., & Thompson, C. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214941 · Cited by 58
Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies
Hu, W. W., Janke, A., Ortler, S., Hartung, H., Leder, C., Kieseier, B. C., & Wiendl, H. (2007) · Neurology · doi:10.1212/01.wnl.0000250240.99311.9d · Cited by 35
A Costimulation-Initiated Signaling Pathway Regulates NFATc1 Transcription in T Lymphocytes
Nurieva, R., Chuvpilo, S. A., Wieder, E., Elkon, K. B., Locksley, R. M., Serfling, E., & Dong, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1096 · Cited by 35
Saatian, B., Yu, X.-Y., Lane, A. P., Doyle, T., Casolaro, V., & Spannhake, E. W. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00132.2003 · Cited by 35
Wiley, R. E., Goncharova, S. I., Shea, T., Johnson, J. R., Coyle, A. J., & Jordana, M. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0220oc · Cited by 35
T cells and cytokines in systemic sclerosis
Fuschiotti, P. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000553 · Cited by 38
Fan, X., Wang, J., Qin, T., Zhang, Y., Liu, W., Jiang, K., & Huang, D. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13411 · Cited by 35
Manikwar, P., Kiptoo, P. K., Badawi, A. H., Büyüktimkin, B., & Siahaan, T. J. (2011) · Medicinal Research Reviews · doi:10.1002/med.20243 · Cited by 37
Immunology of B7-H1 and Its Roles in Human Diseases
Tamura, H., Ogata, K., Dong, H., & Chen, L. (2003) · International Journal of Hematology · doi:10.1007/bf02983556 · Cited by 35
“The counterreceptor of B7h/B7RP-1/B7-H2, named inducible costimulator (ICOS), is expressed on activated T-cells but not on resting or naive T-cells in humans [18] or mice [19].”
BackgroundA functional role for inducible costimulator (ICOS) in atherosclerosis
Afek, A. B., Harats, D., Roth, A., Keren, G., & George, J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.040 · Cited by 34
Chen, L., Martinez, O., Venkataramani, P., Lin, S.-X., Prabhakar, B. S., & Chan, L. S. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02691.x · Cited by 34
Costimulation of Memory T-Cells by ICOS: A Potential Therapeutic Target for Autoimmunity?
Sporici, R. A., & Perrin, P. J. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5093 · Cited by 37
AILIM/ICOS signaling induces T-cell migration/polarization of memory/effector T-cells
Okamoto, N., Nukada, Y., Tezuka, K., Ohashi, K., Mizuno, K., & Tsuji, T. (2004) · International Immunology · doi:10.1093/intimm/dxh153 · Cited by 34
Ling, V., Wu, P. W., Miyashiro, J. S., Marušić, S., Finnerty, H. F., & Collins, M. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7300 · Cited by 36
Franzese, O., Palermo, B., Donna, C. D., Sperduti, I., Ferraresi, V., Stabile, H., Gismondi, A., Santoni, A., & Nisticò, P. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1114203 · Cited by 39
Human T Follicular Helper Cells: Development and Subsets
Schmitt, N., & Ueno, H. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6217-0_10 · Cited by 37
Chattopadhyay, K., Bhatia, S., Fiser, A., Almo, S. C., & Nathenson, S. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3920 · Cited by 33
Vermeiren, J., Ceuppens, J. L., Ghelue, M. V., Witters, P., Bullens, D. M. A., Mages, H. W., Kroczek, R. A., & Gool, S. W. V. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5371 · Cited by 33
Self-citationInducible Costimulator: A Modulator of IFN-γ Production in Human Tuberculosis
Quiroga, M. F., Pasquinelli, V., Martínez, G., Jurado, J. O., Zorrilla, L. C., Musella, R. M., Abbate, E. H., Sieling, P. A., & García, V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5965 · Cited by 33
Vidric, M., Tafuri-Bladt, A., Dianzani, U., & Watts, T. H. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1050-1061.2006 · Cited by 33
Cytokines in airway inflammation
Riffo‐Vasquez, Y., Pitchford, S. C., & Spina, D. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00029-7 · Cited by 33
Guo, L., Fujino, M., Kimura, H., Funeshima, N., Kitazawa, Y., Harihara, Y., Tezuka, K., Makuuchi, M., Suzuki, S., & Li, X. (2003) · Transplant Immunology · doi:10.1016/s0966-3274(03)00016-9 · Cited by 33
Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response
Felix, J., Lambert, J., Roelens, M., Maubec, E., Guermouche, H., Pages, C., Sidina, I., Cordeiro, D. J., Maki, G., Chasset, F., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1136045 · Cited by 32
The Glycosylation of Immune Checkpoints and Their Applications in Oncology
Zheng, L., Yang, Q. E., Li, F., Zhu, M. C., Yang, H., Tan, T., Wu, B., Liu, M., Xu, C. S., Yin, J., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15121451 · Cited by 33
Role of Co-stimulatory Molecules in T Helper Cell Differentiation
Schorer, M., Kuchroo, V. K., & Joller, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_6 · Cited by 33
Harnessing the immune system by targeting immune checkpoints: Providing new hope for Oncotherapy
Yu, L., Sun, M., Zhang, Q., Zhou, Q., & Wang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.982026 · Cited by 33
“Specifically, it shares common signaling mechanisms with CD28, and increases T cell responses by stimulating T-cell proliferation and cytokine secretion (169).”
BackgroundDianzani, C., Minelli, R., Mesturini, R., Chiocchetti, A., Barrera, G., Boscolo, S., Sarasso, C., Gigliotti, C. L., Sblattero, D., Yagi, J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903269 · Cited by 32
Lund, R., Ylikoski, E. K., Aittokallio, T. A., Nevalainen, O., & Lahesmaa, R. (2003) · European Journal of Immunology · doi:10.1002/eji.200323899 · Cited by 32
Association of the CD28/CTLA4/ICOS polymorphisms with susceptibility to rheumatoid arthritis
Kim, Y. O., Kim, H. J., Kim, S. K., Chung, J., & Hong, S. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.074 · Cited by 32
Involvement of HAb18G/CD147 in T cell activation and immunological synapse formation
Hu, J., Dang, N., Yao, H., Li, Y., Zhang, H., Yang, X.-M., Xu, J., Bian, H., Xing, J., Zhu, P., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01012.x · Cited by 32
Nonimmune cell–derived ICOS ligand functions as a renoprotective αvβ3 integrin–selective antagonist
Koh, K. H., Cao, Y., Mangos, S., Tardi, N. J., Dande, R. R., Lee, H. W., Samelko, B., Altintas, M. M., Schmitz, V. P., Lee, H., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123386 · Cited by 32
Shilling, R. A., Bandukwala, H. S., & Sperling, A. I. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.04.574 · Cited by 36
Genetic defects in common variable immunodeficiency
Kopecký, O., & Lukešová, Š. (2007) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2007.00681.x · Cited by 32
de Jong, Y. P., Rietdijk, S. T., Faubion, W. A., Abadia-Molina, A. C., Clarke, K., Mizoguchi, E., Tian, J., Delaney, T., Manning, S., Gutierrez-Ramos, J.-C., et al. (2004) · International Immunology · doi:10.1093/intimm/dxh019 · Cited by 32
Miyahira, Y., Akiba, H., Ogawa, S.-H., Ishi, T., Watanabe, S., Kobayashi, S., Takeuchi, T., Aoki, T., Tezuka, K., Abe, R., et al. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00137-8 · Cited by 32
(2020) · doi:10.1101/2020.06.08.138826 · Cited by 31
“, and Kroczek, R.A. (1999). ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.”
InfluentialStimulating T Cells Against Cancer With Agonist Immunostimulatory Monoclonal Antibodies
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.07.003 · Cited by 30
ICOS signaling limits regulatory T cell accumulation and function in visceral adipose tissue
Mittelsteadt, K. L., Hayes, E. T., & Campbell, D. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201142 · Cited by 31
“…production in CD4+ T cells while loss of ICOS signaling in vivo results in reduced TR abundance and IL-10 expression in models of autoimmunity, allergy, and infection (Busse et al., 2012; Hutloff et al., 1999; Kohyama et al., 2004; Kornete et al., 2012; Landuyt et al., 2019; Redpath et al., 2013).”
BackgroundInfluentialVaccination reshapes the virus-specific T cell repertoire in unexposed adults
Pan, Y., Aiamkitsumrit, B., Bartolo, L., Wang, Y., Lavery, C. L. M., Marc, A., Holec, P. V., Rappazzo, C. G., Eilola, T., Gimotty, P. A., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.023 · Cited by 31
Gao, X., Zhao, L., Wang, S., Yang, J., & Yang, X. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00035 · Cited by 32
Gao, X., Gigoux, M., Yang, J., Leconte, J., Yang, X., & Suh, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052657 · Cited by 31
Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage
Yamashita, T., Tamura, H., Satoh, C., Shinya, E., Takahashi, H., Chen, L., Kondo, A., Tsuji, T., Dan, K., & Ogata, K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0501 · Cited by 31
The role of positive costimulatory molecules in transplantation and tolerance
Agarwal, A., & Newell, K. A. (2008) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328306115b · Cited by 31
The T Cell Surface—How Well Do We Know It?
Evans, E. J., Hene, L., Sparks, L. M., Dong, T., Retière, C., Fennelly, J. A., Manso-Sancho, R., Powell, J., Braud, V. M., Rowland‐Jones, S., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00198-5 · Cited by 31
Modulation of CTLA-4 and GITR for Cancer Immunotherapy
Avogadri, F., Yuan, J. D., Yang, A. S., Schaer, D., & Wolchok, J. D. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_49 · Cited by 33
Protective Effector Memory CD4 T Cells Depend on ICOS for Survival
Moore, T. V., Clay, B. S., Ferreira, C. M., Williams, J. W., Rogozinska, M., Cannon, J. L., Shilling, R. A., Marzo, A. L., & Sperling, A. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016529 · Cited by 30
Dickinson, A. M., & Norden, J. (2015) · International Journal of Immunogenetics · doi:10.1111/iji.12202 · Cited by 30
Metadata
- Authors
- Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A.
- Affiliations
- Robert Koch Institute (DE)
- Max Delbrück Center (DE)
- Freie Universität Berlin (DE)
- Corresponding author
- Kroczek, Richard A.
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6716
- Pages
- 263-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1661441964
- Cited by
- 1,482
- References
- 30
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 52 · 2023: 41 · 2022: 66 · 2021: 54 · 2020: 60 · 2019: 53 · 2018: 52 · 2017: 32 · 2016: 44 · 2015: 41 · 2014: 35 · 2013: 53 · 2012: 47
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- ICOS, CD28, CTLA-4, T cell costimulation, T cell proliferation, lymphokine secretion, IL-10, B cell help, germinal center, adaptive immune regulation
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, Cell Communication, Cell Line, Cloning, Molecular, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Molecular Sequence Data, T-Lymphocytes, CD28 Antigens, Germinal Center, Mice, Inducible T-Cell Co-Stimulator Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.